Literature DB >> 3514044

Pharmacokinetic determinants of drug abuse and dependence. A conceptual perspective.

U Busto, E M Sellers.   

Abstract

Drugs that produce physical dependence or have similar pharmacological profiles to highly abused drugs are unlikely to be considered acceptable for marketing. Thus, the prediction of abuse and dependence becomes an important issue in the development of new psychotropic drugs. Both pharmacokinetic and non-pharmacokinetic factors play an important role in predicting dependence and abuse liability of drugs. Evidence for the importance of pharmacological factors includes: the demonstration of drug binding to receptors of abused drugs; tolerance; ability to maintain self-administration; and spontaneous or antagonist precipitated withdrawal. The pharmacokinetic properties that presumably contribute to persistent self-administration and abuse include rapid delivery of drug to the central nervous system (CNS), rapid absorption, low protein binding and high free drug clearance. The pharmacokinetic properties of a drug associated with dependence will include long half-life, low free drug clearance and presence of the drug in the body at high enough concentrations and for sufficient time to permit tolerance to develop. These properties have important clinical implications for treatment and research in the area of abuse and dependence liability of psychoactive drugs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514044     DOI: 10.2165/00003088-198611020-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  49 in total

1.  The importance of dissociaton constant and lipid-solubility in influencing the passage of drugs into the cerebrospinal fluid.

Authors:  B B BRODIE; H KURZ; L S SCHANKER
Journal:  J Pharmacol Exp Ther       Date:  1960-09       Impact factor: 4.030

2.  Lorazepam withdrawal seizures.

Authors:  T R Einarson
Journal:  Lancet       Date:  1980-01-19       Impact factor: 79.321

3.  Changing pattern of drugs used for self-poisoning.

Authors:  A T Proudfoot; J Park
Journal:  Br Med J       Date:  1978-01-14

4.  Brain uptake of phenytoin, phenobarbital, and diazepam.

Authors:  R E Ramsay; E J Hammond; R J Perchalski; B J Wilder
Journal:  Arch Neurol       Date:  1979-09

5.  Diagnosis and management of depressant drug dependence.

Authors:  J A Ewing; W E Bakewell
Journal:  Am J Psychiatry       Date:  1967-02       Impact factor: 18.112

6.  Intravenous phenobarbital therapy in barbiturate and other hypnosedative withdrawal reactions: a kinetic approach.

Authors:  P R Martin; C M Bhushan; B M Kapur; E A Whiteside; E M Sellers
Journal:  Clin Pharmacol Ther       Date:  1979-08       Impact factor: 6.875

7.  Self-injection of barbiturates and benzodiazepines in baboons.

Authors:  R R Griffiths; S E Lukas; L D Bradford; J V Brady; J D Snell
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  Diazepam tapering in detoxification for high-dose benzodiazepine abuse.

Authors:  M Harrison; U Busto; C A Naranjo; H L Kaplan; E M Sellers
Journal:  Clin Pharmacol Ther       Date:  1984-10       Impact factor: 6.875

9.  Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats.

Authors:  J R WEEKS
Journal:  Science       Date:  1962-10-12       Impact factor: 47.728

10.  Ethanol ingestion: differences in blood acetaldehyde concentrations in relatives of alcoholics and controls.

Authors:  M A Schuckit; V Rayses
Journal:  Science       Date:  1979-01-05       Impact factor: 47.728

View more
  20 in total

Review 1.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

Review 3.  Behavioral mechanisms underlying nicotine reinforcement.

Authors:  Laura E Rupprecht; Tracy T Smith; Rachel L Schassburger; Deanne M Buffalari; Alan F Sved; Eric C Donny
Journal:  Curr Top Behav Neurosci       Date:  2015

4.  Increased vulnerability to cocaine in mice lacking dopamine D3 receptors.

Authors:  Rui Song; Hai-Ying Zhang; Xia Li; Guo-Hua Bi; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

5.  The rate of dasotraline brain entry is slow following intravenous administration.

Authors:  Robert Lew; Cristian C Constantinescu; Daniel Holden; Richard E Carson; Vincent Carroll; Gerald Galluppi; Kenneth S Koblan; Seth C Hopkins
Journal:  Psychopharmacology (Berl)       Date:  2020-08-19       Impact factor: 4.530

6.  T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice.

Authors:  Xiao-Fei Wang; Elisabeth Barbier; Yi-Ting Chiu; Yi He; Jia Zhan; Guo-Hua Bi; Hai-Ying Zhang; Bo Feng; Lee-Yuan Liu-Chen; Jia Bei Wang; Zheng-Xiong Xi
Journal:  J Neurosci       Date:  2016-10-05       Impact factor: 6.167

7.  CTDP-32476: A Promising Agonist Therapy for Treatment of Cocaine Addiction.

Authors:  Zheng-Xiong Xi; Rui Song; Xia Li; Guan-Yi Lu; Xiao-Qing Peng; Yi He; Guo-Hua Bi; Siyuan Peter Sheng; Hong-Ju Yang; Haiying Zhang; Jin Li; Mark Froimowitz; Eliot L Gardner
Journal:  Neuropsychopharmacology       Date:  2016-08-18       Impact factor: 7.853

8.  Subjective and behavioral effects of diazepam depend on its rate of onset.

Authors:  H de Wit; S Dudish; J Ambre
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 9.  Wake-promoting pharmacotherapy for psychiatric disorders.

Authors:  Bernardo Dell'Osso; Cristina Dobrea; Laura Cremaschi; Chiara Arici; A Carlo Altamura
Journal:  Curr Psychiatry Rep       Date:  2014-12       Impact factor: 5.285

10.  Retrospective population cohort study on hip fracture risk associated with zolpidem medication.

Authors:  Fang-Yu Lin; Pei-Chun Chen; Chun Hui Liao; Yow-Wen Hsieh; Fung-Chang Sung
Journal:  Sleep       Date:  2014-04-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.